MAPT and Alzheimer disease: The defining clinical characteristics seen in the brain cells of individuals with AD are elevated concentrations of both amyloid‐β (Aβ), which forms extracellular senile plaques, and hyperphosphorylated tau (hTau), which aggregates intracellularly as neurofibrillary tangles (NFTs) [2, 3].